产品描述
DO:03260672, PEDIDO 4700062963, DECLARACION 1 DE 1, // FACTURA:FS20251010, FECHA:10-10-2025 PRODUCTO: MATERIA PRIMA PARA MEDICAMENTO, SULTAMICILINA TOSILATO DIHIDRATO, NOMBRE COMERCIAL: SULTAMICILINA TOSILATO DIHIDRATO, NO. CAS (NUMERO DE REGISTRO DEL CHEMICAL ABSTRACTS SERVICE): 83105-70-8, CALIDAD: METODO ALINEADO A FARMACOPEA USP/NF VIGENTE, ASPECTO FISICO: POLVO CRISTALINO BLANCO A CASI BLANCO, CONCENTRACION: 95,0% - 102,0%., TIPO DE EMPAQUE: TAMBOR DE 25 KG, USO: MATERIA PRIMA PARA LA FABRICACION DEMEDICAMENTOS DE USO HUMANO, PRODUCTO TERMINADO SULTAMICILINA 375 MG TABLETAS RECUBIERTAS., MARCA: NO TIENE , NOMBRE QUIMICO: 4-METHYLBENZENESULFONATE OF METHYLENE (2S,5R,6R)-6-(((2R)-AMINOPHENYLACETYL)AMINO)-3,3-DIMETHYL-7-OXO-4-THIA-1-AZABICYCLO (3.2.0)HEPTANE-2-CARBOXYLATE(2S,5R)-3,3-DIMETHYL-4,4,7-TRIOXO-4L6-THIA-1-AZABICYCLO (3.2.0)HEPTANE-2-CARBOXYALTE DIHYDRATE, FORMULA MOLECULAR: C32H38N4O12S3¿2H2O, LABORATORIO FABRICANTE: JIANGXI FUSHINE PHARMACEUTICAL CO., LTD, PAIS DE ORIGEN: CHINA, NO. DE EXPEDIENT
展开
交易日期
2026/02/28
提单编号
6312712
供应商
jiangxi fushine pharmaceuticals co
采购商
apitoria pharma private limited
出口港
——
进口港
visakhapatnam
供应区
China
采购区
India
重量
——
金额
127000
HS编码
29411090
产品标签
sulbactam acid
产品描述
SULBACTAM ACID SULBACTAM ACID
展开
交易日期
2026/02/28
提单编号
4356231
供应商
jiangxi fushine pharmaceuticals co
采购商
apitoria pharma private limited
出口港
——
进口港
visakhapatnam
供应区
China
采购区
India
重量
——
金额
381000
HS编码
29411090
产品标签
sulbactam acid
产品描述
SULBACTAM ACID SULBACTAM ACID
展开
交易日期
2026/02/04
提单编号
0125337
供应商
jiangxi fushine pharmaceuticals co
采购商
aurobindo pharama ltd.
出口港
——
进口港
hyderabad
供应区
China
采购区
India
重量
——
金额
390000
HS编码
29337990
产品标签
ester,keto,bic
产品描述
BICYCLIC KETOESTER BICYCLIC KETOESTER
展开
交易日期
2026/01/21
提单编号
107911665741
供应商
jiangxi fushine pharmaceuticals co
采购商
công ty cp xuất nhập khẩu y tế domesco
产品描述
Nguyên liệu mẫu nhập khẩu để dùng cho NC-SX thuốc, không sử dụng vào mục đích khác, không lưu thông trên thị trường: SULTAMICILLIN TOSILATE DIHYDRATE EP11, Lot: Z035-2504043, Z035-2504044,
展开